PAK2 is an effector of TSC1/2 signaling independent of mTOR and a potential therapeutic target for Tuberous Sclerosis Complex
Maria M. Alves(Erasmus MC), Maikel P. Peppelenbosch(Universidade Estadual de Campinas (UNICAMP))
Cited by 47
Related Papers
Cytotoxicity of apigenin on leukemia cell lines: implications for prevention and therapy
|Cell Death and Disease|2010|190
Violacein Induces Death of Resistant Leukaemia Cells via Kinome Reprogramming, Endoplasmic Reticulum Stress and Golgi Apparatus Collapse
|PLoS ONE|2012|52
Human mesenchymal stromal cells in adhesion to cell‐derived extracellular matrix and titanium: Comparative kinome profile analysis
|Journal of Cellular Physiology|2018|27